share_log
Breakings ·  Mar 24 07:33

Gendrive has announced that the USA FDA has approved the new drug clinical trial application for the tumor-associated antigen vaccine EVM14.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment